Incorporating (18)FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation

BACKGROUND: To investigate whether the incorporation of (18)FDG-PET into the automatic treatment planning process may be able to decrease the dose to active bone marrow (BM) for locally advanced anal cancer patients undergoing concurrent chemo-radiation (CHT-RT). METHODS: Ten patients with locally a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Franco, Pierfrancesco, Fiandra, Christian, Arcadipane, Francesca, Trino, Elisabetta, Giglioli, Francesca Romana, Ragona, Riccardo, Ricardi, Umberto
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Technical Advance
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5668955/
https://ncbi.nlm.nih.gov/pubmed/29096619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3708-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi